HPV-16-related proteins as the serologic markers in cervical neoplasia

Gynecologic Oncology

Volumn 69, Issue 1, 1998, Pages 47-55

  Park, Jong Sup ^a,c   Park, Dong Choon ^a   Kim, Chan Joo ^a   Ahn, Hee Kyung ^a   Um, Soo Jong ^a   Park, Sue Nie ^b   Kim, Seung Jo ^a   Namkoong, Sung Eun ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; VIRUS DNA; VIRUS PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RADIOIMMUNOASSAY; RADIOIMMUNOPRECIPITATION; SEROLOGY; UTERINE CERVIX TUMOR; WART VIRUS;

EID: 0032054939     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.4963     Document Type: Article

References (44)

1. Mackay EV, Khoo SK, Daunter B: Tumor Markers, in Coppleson M (ed): Gynecologic Oncology. London, UK, Churchill Livingstone, 1992, pp 405-418.
2. Chee YH, Namkoong SE, Kim DH, Kim SJ, Park JS: Immunologic diagnosis and monitoring of cervical cancers using in vitro translated proteins. Gynecol Oncol 57:226-231, 1995
3. Fisher SG, Benitez-Bribiesca L, Stockfleth E, Muller M, Wolf H, Perez-Garcia F, Guzman-Gaona J, Gutierrez-Delgado F, Irvin W, Gissmann L: The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer. Gynecol Oncol 61:73-78, 1996
4. Statistics of Cancer Registration in Korean by Ministry of Health and Social Affair, 1995
5. Disaia PJ, Haveback BJ, Dyce BJ: CEA in cervical and vulvar gynecologic malignancies. Am J Obstet Gynecol 121:159-163, 1975
6. Rose PG, Baker S, Fournier L, Nelson BE, Hunter RF: Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence. Am J Obstet Gynecol 168:942-946, 1993
7. Brinton LA: Epidemiology of Cervical Cancer-Overview, in Munoz N, Bosch FX, Shah KV, Meheus A (eds): The Epidemiology of Cervical Cancer and Human Papillomavirus. Oxford, UK, Oxford Univ Press, 1992, pp 3-23
8. Lorinzc AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ: Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337, 1992
9. Park JS, Chee YH, Namkoong SE, Han SK, Kim TE, Lee HY, Kim SJ: Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction. Gynecol Oncol 53:344-351, 1994
10. Baker CC, Phelps WC, Lindgrn V, Braun MJ, Gonda MA, Howley PM: Structural and transcriptional analysis of humal papillomavirus-16 sequences in cervical carcinoma cell lines. J Virol 61:962-971, 1987
11. zur Hausen H: Papillomavirus in anogenital cancer as a model to understanding the role of viruses in human cancers. Cancer Res 49:4677-4681, 1989
12. Park JS, Hwang ES, Ahn HK, Kim CJ, Chung KT, Kim HS, Park SN, Namkoong SE, Kim SJ: Seroreactivities to HPV-16 VLPs using ELISA in the patients with cervical neoplasia. Kor J Obstet Gynecol 39:176-185, 1996
13. Park JS, Rhyu KS, Kim CJ, Kim HS, Han KT, Ahn HK, Kim SJ, Namkoong SE: Presence of oncogenic HPV DNAs in cervical carcinoma tissues and pelvic lymph nodes associating with proliferating cell nuclear antigen expression. Gynecol Oncol 60:418-423, 1996
14. Saiki RK, Bugawa TL, Horn GT, Erlich HA: Analysis of enzymatically amplified beta-globin and HLA-DQ-alpha DNA with allele specific oligonucleotide probes. Nature 324:574-578, 1986
15. Crombach G, Scharl A, Vierbuchen M, Wurz H, Boite A: Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix. Cancer 63:1337-1342, 1982
16. Kirnbauer R, Taub J, Greenstone H, Doden R, Durst M, Gissmann L, Lowy DR, Schiller JT: Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 67:6929-6936, 1993
17. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT: A virus-like particle enzyme-linked immunosorbant assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86:494-499, 1994
18. Viscidi RP, Sun Y, Tsuzaki B, Bosch FX, Munoz N, Shah KV: Serologic response in human papillomavirus associated invasive cervical cancer. Int J Cancer 55:780-784, 1993
19. Gold P, Shuster J, Freedman SO: Carcinoembryonic antigen (CEA) in clinical medicine: historical perspectives, pitfalls and projections. Cancer 42:1399-1405, 1978
20. van Nagell JR, Donaldson ES, Wood EG, Goldenberg DM: The clinical significance of CEA in the plasma and tumors of patients with gynecological malignancies. Cancer 42:1527-1532, 1978
21. Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M: Tumor associated antigen. T4-4 in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix; serial determinations and tissue localization. Cancer 56:302-308, 1985
22. Kato H, Tami K, Nagaya T, Nagai M, Torigoe H: The use of a tumor antigen TA-4 for the management of squamous cell carcinoma. Cancer Detect Prev 8:115-119, 1985
23. Senekjian EK, Young JM, Weiser PA, Spencer CE, Magic SE, Herbst AL: An evaluation of squamous cell carcinoma antigen in patients with cervical cell carcinoma. Am J Obstet Gynecol 157:433-439, 1987
24. Crombach G, Scharl A, Vierbuchen M, Hannelore W, Boite A: Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cavity. Cancer 63:1337-1342, 1989
25. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen AC, Kurman RJ: Human papillomavirus testing by hybrid capture is useful in triaging women with a cytologic diagnosis of ASCUS. Am J Obstet Gynecol 172:946-954, 1995
26. Park JS: The role of HPV DNA testing in cervical neoplasia. J Obstet Gynecol Res 6:611-620, 1996
27. Dillner J: Antibody response to defined HPV epitopes in cervical neoplasia. Papillomavirus Rep 5:35-42, 1994
28. Jenison SA, Yu XP, Valentine JM, Galloway DA: Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. J Virol 65:1208-1218, 1991
29. Jochmus-Kudielka I, Schneider A, Braun R, Kimming R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L: Antibodies against the human papillomavirus type 16 early proteins in human sera, correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 81:1698-1704, 1989
30. Mandelson MT, Jenison SA, Sherman KJ, Valentine JM, Mcknight B, Daling JR, Galloway DA: The association of human papillomavirus antibodies with cervical risk. Cancer Epidemiol Biomark Prev 1:281-286, 1992
31. Cason J, Khan SA, Best JM: Towards vaccines against human papillomavirus type-16 genital infections. Vaccine 11:603-611, 1993
32. Tindle RW, Frazer IH: Human papillomavirus infection, genital warts and cervical cancer: prospects for prophylactic and therapeutic vaccines. Exp Opin Invest Drugs 4:783-797, 1995
33. Bonnez W, DaRin C, Rose RC, Reichman RC: Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condyloma acuminata. J Gen Virol 72:1343-1347, 1991
34. Hines JF, Ghim SJ, Christensen ND, Kreider JW, Barns WA, Schlegel R, Jensen AB: Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination. Gynecol Oncol 55:13-20, 1994
35. Lowy DR, Kirnbauer R, Schiller JT: Genital human papillomavirus infection. Proc Natl Acad Sci USA 91:2436-2440, 1994
36. Muller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, Bosch FX, Munoz N, Gissmann L, Shah KV: Antibodies to HPV-16 E6 and E7 proteins as marker for HPV-16-associated invasive cervical cancer. Virology 187:508-514, 1992
37. Sun Y, Eluf-Neto J, Bosch FX, Munoz N, Booth M, Walboomers JMM, Shah KV: Human papillomavirus (HPV)-related serologic markers of invasive cervical carcinoma in Brazil. Cancer Epidemiol Biomark Prev 3:341-347, 1994
38. Coleman N, Greenfield IM, Hare J, Kruger-Gray N, Chain BM, Stanley MA: Characterization and functional analysis of the expression of intracellular adhesion molecule-1 (ICAM-1) in human papillomavirus-related disease of cervical keratinocytes. Am J Pathol 143:355-367, 1993
39. Braun L, Mikumo R, Mark HFL, Lauchlan S: Analysis of the growth properties and physical state of the human papillomavirus type 16 genome in cell lines derived from primary cervical cancers. Am J Pathol 143:832-844, 1993
40. Dyson N, Howley PM, Munger K, Harlow E: The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937, 1993
41. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79, 1990
42. Campo MS: Vaccination against Papillomavirus in Cattle, in zur Hausen H (ed): Human Pathogenic Papillomaviruses. Berlin, Springer Verlag; Curr Top Microbiol Immnol 186:255-266, 1994
43. Chandrachud LM, O'Neil BW, Jarrett WFH, Grindlay GA, McGravie GM, Campo MS: Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitope. Virology 200: 98-104, 1994
44. Cole JS, Gruber J: Progress and prospects for human cancer vaccines. J Natl Cancer Inst 84:18-23, 1992